Brief: Sprint Bioscience Q4 operating loss widens to SEK 4.0 million

Sprint Bioscience AB

24/02/2016 07:30

Feb 24 (Reuters) - Sprint Bioscience AB  SPRINT.ST : 
    * Q4 operating loss 4.0 million Swedish crowns versus loss 3.7 million crowns year ago 
    * Q4 revenue 5.8 million crowns versus 2.2 million crowns year ago 
    * Gives no 2016 outlook 
    * Proposes no FY 2015 dividend 
 
Source text for Eikon:  ID:nWkrbw3358  
     
Further company coverage:  SPRINT.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))